États-Unis · Plateformes & données · Yahoo Finance

Xenetic Biosciences Announces Oral Presentation at 68th ASH Annual Meeting Highlighting DNase I as a Potential Strategy to Overcome CAR T-Cell Resistance

Publié par Yahoo Finance · États-Unis il y a 9 h

The conference will take place December 12-15, 2026, in New Orleans, Louisiana, and virtually.The presentation will examine how extracellular chromatin released during CAR T-cell…

Lire l'article complet sur Yahoo Finance Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finance.yahoo.com)

Xenetic Biosciences Announces Oral Presentation at 68th ASH Annual Meeting Highlighting DNase I as a Potential Strategy to Overcome CAR T-Cell Resistance

À lire aussi

Oportun Financial (NASDAQ:OPRT) Sets New 12-Month High After Better-Than-Expected Earnings

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

2 Berkshire Hathaway Holdings to Buy After Record Third Quarters

Democrats win control of Congress as voters rebuke Trump agenda

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5

Xenetic Biosciences Announces Oral Presentation at 68th ASH Annual Meeting Highlighting DNase I as a Potential Strategy to Overcome CAR T-Cell Resistance

Partager

À lire aussi

Oportun Financial (NASDAQ:OPRT) Sets New 12-Month High After Better-Than-Expected Earnings

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

2 Berkshire Hathaway Holdings to Buy After Record Third Quarters

Democrats win control of Congress as voters rebuke Trump agenda

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5